C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/00 (2006.01) A61K 39/29 (2006.01) A61K 39/39 (2006.01) A61K 48/00 (2006.01) C07H 21/04 (2006.01)
Patent
CA 2289741
The invention provides oligonucleotide adjuvants useful for the generation of both a cell mediated (cytotoxic T lymphocyte) response and an antibody response to an antigen presented by the administration of a vaccine. Vaccine compositions including the adjuvant and methods of vaccination using the adjuvants are also provided.
L'invention concerne des adjuvants oligonucléotidiques utiles pour provoquer à la fois une réaction à médiation cellulaire (lymphocytes T cytotoxiques) et une réaction immunitaire à un antigène présenté par l'administration d'un vaccin. Des compositions de vaccins renfermant l'adjuvant et des procédés de vaccination employant les adjuvants sont également prévus.
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Oligonucleotide adjuvant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotide adjuvant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotide adjuvant will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1877069